Collegium Pharmaceutical (COLL) Insider Trading & Ownership → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free COLL Stock Alerts $33.19 +1.83 (+5.84%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Collegium Pharmaceutical (NASDAQ:COLL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.98%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$5.92 M Get COLL Insider Trade Alerts Want to know when executives and insiders are buying or selling Collegium Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address COLL Insider Buying and Selling by Quarter Ad American AlternativeYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW Collegium Pharmaceutical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/28/2024Colleen TupperCFOSell19,710$34.21$674,279.10 5/24/2024Scott DreyerEVPSell56,807$33.98$1,930,301.86 5/14/2024Garen G BohlinDirectorSell28,985$32.30$936,215.50 1/16/2024Scott DreyerEVPSell23,560$32.28$760,516.80 12/21/2023Joseph CiaffoniCEOSell4,357$30.38$132,365.66 12/19/2023Joseph CiaffoniCEOSell14,516$30.03$435,915.48 11/27/2023Shirley R KuhlmannEVPSell25,600$25.78$659,968.00 6/26/2023Shirley R KuhlmannEVPSell17,984$21.72$390,612.48 (Data available from 1/1/2013 forward) COLL Insider Trading Activity - Frequently Asked Questions Who is on Collegium Pharmaceutical's Insider Roster? The list of insiders at Collegium Pharmaceutical includes Colleen Tupper, Garen G Bohlin, Joseph Ciaffoni, Michael Thomas Heffernan, Scott Dreyer, and Shirley R Kuhlmann. Learn more on insiders at COLL. What percentage of Collegium Pharmaceutical stock is owned by insiders? 3.98% of Collegium Pharmaceutical stock is owned by insiders. Learn more on COLL's insider holdings. Which Collegium Pharmaceutical insiders have been selling company stock? The following insiders have sold COLL shares in the last 24 months: Colleen Tupper ($1,501,834.40), Garen G Bohlin ($936,215.50), Joseph Ciaffoni ($4,266,166.18), Michael Thomas Heffernan ($1,869,314.79), Scott Dreyer ($3,535,042.72), and Shirley R Kuhlmann ($2,340,166.39). How much insider selling is happening at Collegium Pharmaceutical? Insiders have sold a total of 564,458 Collegium Pharmaceutical shares in the last 24 months for a total of $14,448,739.98 sold. More Insider Trading Tools from MarketBeat Related Companies: NKTR Insider Buying INZY Insider Buying EGRX Insider Buying ALPN Insider Buying NUVL Insider Buying ALKS Insider Buying PRGO Insider Buying CRNX Insider Buying AXSM Insider Buying BHVN Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Top 4 Stocks With Notable Insider Buying3 Small Cap Tech Stocks That Insiders Are Buying3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying This page (NASDAQ:COLL) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collegium Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.